Bradford K. Amman, Chief Financial Officer at Vivos Therapeutics, Inc. (VVOS), bought 1,000 shares at $7.38 ($7K) on 2020-12-24, disclosed to the SEC on 2020-12-28.
Open-market purchase of $7k VVOS by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |